Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Jochen Reiser |
Contact phone | 305-243-2349 |
Contact email | jreiser@med.miami.edu |
Dua signed dt | Sept. 29, 2010, midnight |
PI name | Jochen Reiser, Changli Wei |
Site approved dt | April 15, 2010, midnight |
Niddk signed dt | Oct. 18, 2010, midnight |